About: Nanobiotix S.A. operates as a clinical-stage biotechnology that focuses on developing product candidates for the treatment of cancer and other unmet medical needs. Its lead product candidate is NBTXR3, a sterile aqueous suspension of crystalline hafnium oxide nanoparticles used for the treatment of soft tissue sarcoma, head and neck, liver, prostate, pancreatic, esophageal, rectal, and non-small cell lung cancer. The company has a partnership with Lian Oncology Limited to develop and commercialize NBTXR3 in China, South Korea, Singapore, and Thailand. Nanobiotix S.A. was incorporated in 2003 and is based in Paris, France.
Sector: Healthcare
Industry: Biotechnology
Latest price: $24.62 (-2.42%)
NBTX NASDAQ Nanobiotix
Nanobiotix share price
NBTX price activity
Last Price
$24.620
Change (24hr)
-0.61 USD (-2.42%)
Volume
142.60K
Volume (4w avg)
-
Open
$24.68
Day Range
$24.31 - $25.12
Previous Close
$25.23
Last Trade
07 Oct, 8:00 pm GMT+0
Delayed
07 Oct, 8:00 pm GMT+0
NBTX price performance
Delayed
07 Oct, 8:00 pm GMT+0
NBTX Market Signals